Author(s):
Priyanka M. Salve, Shital V. Sonawane, Mayuri B. Patil, Rajendra K. Surawase
Email(s):
priyankasalve1126@gmail.com
DOI:
10.52711/2231-5659.2021.00037 
Address:
Priyanka M. Salve*, Shital V. Sonawane, Mayuri B. Patil, Rajendra K. Surawase
Loknete Dr. J. D. Pawar College of Pharmacy, Manur, Tal - Kalwan, Dist - Nashik - 423501.
*Corresponding Author
Published In:
Volume - 11,
Issue - 3,
Year - 2021
ABSTRACT:
Dissolution is an official test. These used by pharmacopeias for evaluating drug release of solid and semisolid dosages forms. The application of the dissolution testing ensures consistent product quality and to predict in vivo drug bioavailability. The dissolution test, in its simplest form, placing the formulation in a dissolution apparatus containing suitable dissolution medium, allowing it to dissolved specified period of time and then using appropriate rational method to determine the amount of drug. Dissolution test are probative and analysis like drug degradation profile, shelf-life studies, stability, physical and mechanical testing of dosage forms. The present review outlines findings on various dissolution apparatus, various methods and their modification. Dissolution testing the of various dosage form like Delayed release dosage form, Immediate release dosage form, Extended-release dosage form, Powders, Chewable tablets, Transdermal delivery system, Buccal tablets, Soft gelatin capsule, Chewing gums, Suppositories, Aerosols and others semisolids. This article goal of the description of the all-official dissolution testing apparatus.
Cite this article:
Priyanka M. Salve, Shital V. Sonawane, Mayuri B. Patil, Rajendra K. Surawase. Dissolution and Dissolution Test Apparatus: A Review. Asian Journal of Research in Pharmaceutical Sciences. 2021; 11(3):229-6. doi: 10.52711/2231-5659.2021.00037
Cite(Electronic):
Priyanka M. Salve, Shital V. Sonawane, Mayuri B. Patil, Rajendra K. Surawase. Dissolution and Dissolution Test Apparatus: A Review. Asian Journal of Research in Pharmaceutical Sciences. 2021; 11(3):229-6. doi: 10.52711/2231-5659.2021.00037 Available on: https://ajpsonline.com/AbstractView.aspx?PID=2021-11-3-9
REFERENCES:
1. Brahmankar DM, Jaiswal SB, Biopharmaceutics a Treastise and Pharmacokinetics, GT Karnal Road, Delhi: 2009. Pg.29-55.and 328-335.
2. Khar RK, Vyas SP, Ahmad FJ, Jain GK., Lachman L, Liberman HA. The Theory and Practice of Industrial Pharmacy.4th Edition. Ansari road Daryaganj, New Delhi, India; 2013.pg-182-198.
3. United State of Pharmacopeia, 2009. pg.263-276.
4. Hasan Mehdi md, Rahman Mizanur md, Islam Rakibul md, Hasan H, Rashid heron Ar. (A key approach on dissolution of pharmaceutical dosage forms) The Parma Innovation Journal 2017; 6(9): 168-180.
5. http://www.table dissolution.com/eduction/baskets-and-shafts/index.php.
6. Hasan MM, Uddin F, Islam MM, Hasan M, Banik K, islam MA, Hashid HA et al. Nonotechnology drug delivery system: tools in advance pharmaceutical and human health care. International Journal of Biopharmaceutics.2016; 7(2): 90-99.
7. Jino Elsa Thomas, Usha Y Nayak, Jagdish PC, Koteshwara KB. Design and Characterization of valsartan Co-Crystal to improve its Aqueous Solubility and Dissolution Behavior. Research J. Phram. And Tech.2017; 10(1): 26-30. doi: 10.5958/0974-360X.2017.00007.5
8. Pillay V, Fassihi R, Unconvetional Dissolution Methodologies. J Pharm Sci.1999; 88(9):834-851.
9. Rekha Kallam, Padma sree K, Srinivas Arutla, MA Bari. Formulation and Evaluation of Extended-Release Matrix Formulation of Metoprolol Succinate. Research J. Pharm. and Tech. 4(1): January 2011; Page 160-164.
10. Jannat E, Arif AA, Hasan MM, Zarziz AB, Rashid HA. Granulation techniques & its updated modules. The Pharma Innovation Journal, 2016; 5 (10)134-141.
11. Mayur N. Ghotkar, Rohit M. Jamdar, Rohit R. Mahajan, Ashwinkumar S. Chougule, Sneha M. Dhavane, Pooja N. Ingole, Ganesh B. vambhurkar. In-vitro Evaluation of different marketed brands of Rabiprazol Tablets using Quality Control Tests. Asian J. Pharm. Ana.2020;10(2)99-102. doi: 10.5958/2231-5675.2020.00017.4
12. Singha and Aboul-Eneinb HY, ʺAdvantages of USP Apparatus IV (Flow-through Cell Apparatus) in Dissolution Studies ʺJournal of the Iranian Chemical Society, Vol.3, No.3.
13. Gitika Dhingra, Brinda Sreelesh, Manju Nagpal, Pankaj Rakha, B P Nagori. In-Vitro Dissolution Testing of Ibuprofen Using Compendial and Biorelevant Dissolution Media. Research J. Pharm.and Tech.3 (3): July-Sept. 2010; Page 931-933.
14. Indian pharmacopoeia, ʺGovernment of India & Ministry of health and welfare ʺedition 1996, Volume- II, Published by Controller of Publication, Delhi.
15. Sudhir Sawant, Ramesh Yamgar. Dealing With the Challenges during Large Scale Manufacturing of Polymophic Drug Substances. Asian J. Res. Pharm. Sci. 1(3): July-Sept.2011; Page 63-68.
16. Crist GB, Trends in Small-Volume Disslution Apparatus for Low-Dose Compounds. Dissolution Technologies.2009; 16 (1):19-22.
17. Swati Saxena, Sarang Jain. A Review on Biopharmaceutical Classification System. Asian J. Pharm. Tech. 2019 ;( 4): 267-270. doi: 10.5958/2231-5713.2019.00044.8
18. Moller H, Dissolution testing of different dosages forms using the flow through method. Pharm Ind.1983; 45:617-622.
19. S. Janani, k. Manikandan, R. Kamaaraj. Overview of Biosilimilars. Research J. Pharm. and Tech 2018; 11(11): 5152-5158. doi: 10.5958/0974-360X.2018.00941.1
20. http://www.pharmatutor.org/articles/review-selection-of-dissolution-media.
21. R. K. Verma. Generic Medicines: Core Issue and Legal mechanism. Int. J. Rev. and. Res. Social Sci. 2019; 7(2): 405-414. doi: 10.5958/2454-2687.2019.00033.9
22. Avdeef A, Box KJ, Comer JE, Gilges M, Hibbert C, et al. PH of water –insoluble drugs in organic solvent-water mixtures. J Pharm Biomed Anal.1999(20):631-41.
23. Rohankumar R. Chavan, Sheela S, Thorat, Aishwarya R Thoke. Degradation Study of Spironoctone by UV-Visible Spectroscopy Method in Bulk Form. Asian J. Pharma. Tech. 2019;9(3): 185-188.doi: 10.5958/2231-5713.2019. 00031. X
24. Kurkura J, Baxter JL, Muzzio FJ. Shear distribution and variability in theUSP Apparatus2 under turbulent conditions. Int J Pharm.2004; (279):9-17.
25. FIP: Fedration International Pharmaceutique. FIP guidelines for dissolution testing of solid oral products. Die Pharmazeuthische Industries.1981;42:334-343
26. USP30and NF 25.US Pharmacopeial Convertion.2007; Rockville, MD.
27. Council of Europe. European Pharmacopoeia.6. strasbourg: Council of Europe;2006.
28. Joshi A, Pund S, Nivsarkar M, Vasu K, Shishoo C. Dissolution test for site specific release isomiazide pellets inUSP apparatus 3(reciprocating cylinder): optimization using response surface methodology. Eur J Pharm Biopharm. 2008; 69:769-75. doi:10.1016/j.ejpb.2007.11.020.
29. Herzfeldt CD, Kummel R. Dissociation constants, solubilities and dissolution rates of some selected nonsteroidal anti-inflammatories, Drug Dev Ind Pharm1983;9:767-93
30. Florence, Alexander T.and Siepmann.Jurgn(2009). Modern Pharmaceutics Application and advance. volume 2nd,5 th edition.pg-34-35
31. Beyssac E, Lavigne J. Dissolution study of Active Pharmaceutical ingredients using the flow through apparatus USP 4. Dissolution Technologies.2005;1:23-5
32. USP: The Topical/Transdermal Ad Hoc Advisory Panel for the USP Performance Tests of Topical and Transdermal Dosage Forms. Topical and Transdermal Drug Products Dissolution Technologies.2010;17(4):12-25
33. Maggio RM, Castellano PM, Kaufman TS. A new principle component analysis –based approach for testing “similarity” of drug dissolution profiles. Eur J Pharm SCI.2008; 34: 66-77.
34. Higuchi WI. Analysis of data on the medicament release from ointments. J Pharm Sci.1962;51: 802-804.
35. http://wwwfdagov/downloads/drugs/.../Guidances/ucm070246pdf.
36. AbdouHM.Dissolution, Bioavailability and Bioequivalence.Easton, PA, Mack publishing,1989, pg-11-36
37. International Conference of Harmonization, ICH Q8 Pharmaceutical Development, www.ich .org; 2 september2008.
38. Laia TY, Carstensen JT. Effect of shape factor on cube root dissolution behavior Ind JPharm biopharm. 1978;1(1):33-40
39. www.pharmpress.com/files/docs/suppositories-sample .pdf
40. Mistry Khushboo, Kavya Naik, Vasanthi, Alica Menezes, Anup Naha, K.B. Koteshwara, K. Girish Pai. Formulation and Evaluation of Irbesartan nanosuspension for Dissolution Enhancement. Research J.Pharm.and Tech. 2017; 10(9):3043-3048. doi: 10.5958/0974-360X.2017.00540.6